Does Nicotine Patch Concentration Gaps in People at Risk for AD?
The same nicotine patch that helps smokers kick the habit boosts the concentration powers of people with mild cognitive impairment...
6389 RESULTS
Sort By:
The same nicotine patch that helps smokers kick the habit boosts the concentration powers of people with mild cognitive impairment...
Why do some people better resist the cognitive declines that typically come with aging?...
While hospital stays are no fun for anyone, such experiences can be particularly traumatic for people with dementia...
Researchers published new U.S. guidelines for the neuropathologic assessment of Alzheimer’s disease last November—the first revision in 14 years...
A study on genetic variants of extreme longevity that was reported in 2010 and later retracted by the authors now appears in revised form...
Previous genome studies suggest that all of us possess a few hundred non-functional genes...
How do glutamine-rich proteins cause neurodegenerative disease?...
In a rare condition known as amyloid-β-related angiitis (ABRA), buildup of amyloid in the brain vasculature is accompanied by swelling in the brain...
While astrocytes can trigger harmful neuroinflammation, they also secrete molecules that may help curb that destruction...
Continued setbacks in Alzheimer’s disease clinical trials have fueled a sense that candidate drugs have been tested in patients whose disease has already progressed too far...
In people with a rare form of amyotrophic lateral sclerosis, every cell produces mutant SOD1, but only certain motor neurons succumb to the toxic protein...
Researchers have been measuring Aβ for decades, trying to nail down its behavior in Alzheimer's patients or those nearing the disease...
Two papers published this month claim to identify those at greatest risk for Alzheimer’s disease and illuminate the mechanisms behind it...
Floundering motor neurons rely on a support network for help, and they send out a distress call to astroglia in the form of angiogenin...
Janssen Alzheimer Immunotherapy and Pfizer, Inc., together with the Geoffrey Beene Gives Back® Alzheimer’s Initiative, announced five finalists for the Alzheimer's Challenge 2012...